Introduction:Basic information about N-isopentyladenosine CAS 17659-78-8, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
N-isopentyladenosine Basic information
| Product Name: | N-isopentyladenosine |
| Synonyms: | N-isopentyladenosine;N-(3-Methylbutyl)adenosine;Adenosine, N-(3-methylbutyl)-;Einecs 241-638-1;N-(3-Methylbutyl)adenosine, N6-Isoamyladenosine;N6-(3-Methylbutyl)adenosine;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(isopentylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol;N6-Isoamyladenosine |
| CAS: | 17659-78-8 |
| MF: | C15H23N5O4 |
| MW: | 337.37 |
| EINECS: | 241-638-1 |
| Product Categories: | |
| Mol File: | 17659-78-8.mol |
|
N-isopentyladenosine Chemical Properties
| Boiling point | 632.9±65.0 °C(Predicted) |
| density | 1.57 |
| pka | 13.12±0.70(Predicted) |
Safety Information
N-isopentyladenosine Usage And Synthesis
| Uses | N-(3-Methylbutyl)adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. |
| References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 [2] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020 |
N-isopentyladenosine Preparation Products And Raw materials